These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33281912)

  • 21. Efficacy of Compound Danshen Dripping Pills combined with western medicine in the treatment of diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials.
    Huang H; Li Y; Huang Q; Lei R; Zou W; Zheng Y
    Ann Palliat Med; 2021 Oct; 10(10):10954-10962. PubMed ID: 34763458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review of compound danshen dropping pill: a chinese patent medicine for acute myocardial infarction.
    Luo J; Xu H; Chen K
    Evid Based Complement Alternat Med; 2013; 2013():808076. PubMed ID: 23843882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X
    J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of adjuvant therapy with compound danshen drip pill on inflammatory factors and cardiac function after percutaneous coronary intervention for acute myocardial infarction: a systematic review and meta-analysis.
    Fan G; Liu M; Song H; Wang Y
    Front Pharmacol; 2024; 15():1345897. PubMed ID: 38689665
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chinese Herbal Medicines for Restenosis After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Zhao L; Lin K; Lu L; Luo C
    J Altern Complement Med; 2019 Oct; 25(10):983-992. PubMed ID: 31464515
    [No Abstract]   [Full Text] [Related]  

  • 28. The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
    Zou JB; Zhang XF; Wang J; Wang F; Cheng JX; Yang FY; Song X; Wang Y; Liang YL; Shi YJ
    Front Pharmacol; 2018; 9():550. PubMed ID: 29915535
    [No Abstract]   [Full Text] [Related]  

  • 29. Percutaneous Coronary Intervention Versus Surgery in Left Main Stenosis-A Meta-Analysis and Systematic Review of Randomised Controlled Trials.
    Khan SU; Rahman H; Arshad A; Khan MU; Lekkala M; Yang T; Mishra A; Kaluski E
    Heart Lung Circ; 2018 Feb; 27(2):138-146. PubMed ID: 28923395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
    Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
    J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways.
    Lei W; Li X; Li L; Huang M; Cao Y; Sun X; Jiang M; Zhang B; Zhang H
    J Ethnopharmacol; 2021 Dec; 281():114438. PubMed ID: 34390798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis.
    Zhou H; Feng XL; Zhang HY; Xu FF; Zhu J
    Exp Ther Med; 2013 Oct; 6(4):1034-1040. PubMed ID: 24137311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabonomic strategy to the evaluation of chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats.
    Xin X; Zou H; Zheng N; Xu X; Liu Y; Wang X; Wu H; Lu L; Su J; Qiu M; Wang X
    Evid Based Complement Alternat Med; 2013; 2013():718305. PubMed ID: 23737844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compound Danshen Dripping Pill Promotes Adaptation to Acute High-Altitude Exposure.
    Li Z; Guo J; Liu C; Shi Y; Li Y; Wang J; Li D; Wang J; Chen Y
    High Alt Med Biol; 2020 Sep; 21(3):258-264. PubMed ID: 32466660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Meta-analysis of efficacy and safety of Shexiang Tongxin Dripping Pills combined with conventional therapy of coronary heart disease].
    Pan J; Zhou JM; Wang XM; Zuo KN; Wang ZH; Lu SQ; Wang W; Zhu WT
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2325-2332. PubMed ID: 34047137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Relationship between Compound Danshen Dripping Pills with Isosorbide Mononitrate in the Treatment of Elderly Patients with Unstable Angina Pectoris.
    Liang Y; Zou J; Zhang X; Wang Y; Tai J; Guo D; Cui C; Wang J; Cheng J; Shi Y
    Evid Based Complement Alternat Med; 2018; 2018():3429151. PubMed ID: 30108652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Xing Z; Tang L; Zhu Z; Huang J; Peng X; Hu X
    Platelets; 2018 Sep; 29(6):589-595. PubMed ID: 28895771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice
    Yang Y; Feng K; Yuan L; Liu Y; Zhang M; Guo K; Yin Z; Wang W; Zhou S; Sun H; Yan K; Yan X; Wang X; Duan Y; Hu Y; Han J
    Acta Pharm Sin B; 2023 Mar; 13(3):1036-1052. PubMed ID: 36970211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
    Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.